Spotlight 3

skip navigation
Home Resources Training Facility Inspection Videos Checklists Biosafety in Microbiological and Biomedical Laboratories (BMBL) Long Term Storage Security Related Information Synthetic Genomics Theft, Loss, Release About Us Forms APHIS/CDC Form 1 - Application for Laboratory Registration for Possession, Use, and Transfer of Select Agents and Toxins APHIS/CDC Form 2 - Request to Transfer Select Agents or Toxin APHIS/CDC Form 3 - Report of Theft, Loss, or Release of Select Agents or Toxin APHIS/CDC Form 4 - Report of Identification of Select Agents or Toxin APHIS/CDC Form 5 - Request for Exemption of Select Agents and Toxins for Public Health or Agricultural Emergency or Investigational/Experimental Product Helpful Information Regulations Guidelines Legislation Exclusions Privacy Statement FOIA Act Accessibility Statement Operations Security Risk Assessments Importing Select Agents Select Agents & Toxins Select Agents and Toxins List Select Agents and Toxins - Exclusions Select Agents and Toxins - Restricted Experiments Permissible Toxin Amounts FAQ's General Security Risk Assessments APHIS/CDC Form 2 - Request to Transfer Select Agents or Toxin APHIS/CDC Form 4 - Report of Identification of Select Agents or Toxin Last Updated: Monday, May 17, 2010
July 13, 2009 SARS-associated coronavirus On July 13, 2009, the Department of Health and Human Services (HHS) published in the Federal Register a notice proposing to add SARS-associated coronavirus (SARS-CoV) to the list of HHS Select Agents and toxins found at 42 CFR 73.3. We are proposing this action because (1) SARS-CoV can cause significant mortality, especially in the elderly; (2) the virus has the capability of easily being transmitted from human to human; (3) there is currently no vaccine or antiviral approved for the treatment or prevention of infections caused by the SARS-CoV virus; and (4) it has been documented that the virus may persist in the environment. Written comments on the proposed addition of SARS-CoV to the list of Select Agents and toxins will be accepted until September 11, 2009. The comments should be marked "SARS-CoV" and mailed to: Centers for Disease Control and Prevention, Division of Select Agents and Toxins, 1600 Clifton Road, MS A-46, Atlanta, GA 30333. Comments may also be e-mailed to: SAPcomments@cdc.gov SARS-CoV notice (PDF Format)	Change Text Size: A A A Print This Page
Home \| Resources \| About Us \| Forms \| Helpful Information \| Operations \| Select Agents & Toxins \| FAQ's